It was found that LAs were associated with increased intratumoral CD8+T cells in melanoma-BM compared with LUAD-BM and the presence of LAs was associated with an increased survival benefit in patients with melanoma-BM but not in those with LUAD-BM.
Noor E. Nader, A. Glathar, Elaine V. Byrnes et al.· Cancer Discovery· 0 citations
Purpose: SMARCB1-deficient renal medullary carcinoma (RMC) is an ultra-rare, lethal malignancy refractory to therapies approved for other renal cell carcinomas, and its rarity makes randomized trials logistically unfeasible. We investigated whether wild-type epidermal growth factor receptor (EGFR) is a therapeutically...
N. Zacharias, Eric S Rupe, Xinyue Chen et al.· Clinical Cancer Research· 0 citations
Background Lung cancer remains the leading cause of cancer-related deaths in the United States with over 124,000 estimated deaths for 2026. Previous studies have found that tumor-adjacent lung tissues may provide additional insight into the immune microenvironment of early-stage NSCLC. Methods Multiplex immunofluoresce...
Isabella Polic, Claudio J. Arrechedera, Jared K. Slone et al.· bioRxiv· 0 citations
This approach identified a unique peptide corresponding to FGFR2b, a splicing isoform of FGFR2, that demonstrated markedly higher tumor enrichment than the alternative FGFR2 isoform, FGFR2c.
N. Shah, Beatriz Alvarado-Hernandez, Xinyue Chen et al.· Clinical Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.